🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Content Elimination

Based on the social media company, the platform has taken down problematic content and banned related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, positive reviews and detailed guides for mixing or injecting at home.

After minutes of entering one group, a vendor shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially serious medical dangers”.